MIT scientist Robert Langer will speak at BIO 2015 on a panel about venture capitalism in biotechnology.
Robert Langer, MIT scientist and professor, will be speaking on a panel at the BIO International Convention 2015. The panel, Thirty Years of Venture Capitalism in Biotechnology, will take place on June 15, 2015 at 12:30 pm EST and will feature discussions on the history of venture capitalism in biotechnology, how it has shaped the industry, and how it has changed over time. Langer, the 2014 winner of the Biotechnology Heritage Award, which is presented by the Chemical Heritage Foundation every year at BIO Convention, will be joined on the panel by two other winners of this award: Moshe Alafi (2015 winner), a venture capitalist in biotechnology, and Joshua Boger (2011 winner), an entrepreneur and co-founder of Vertex Pharmaceuticals.
For more information on BIO International Convention 2015, please visit BIO 2015. The convention will be held June 15 to June 18, 2015 in Philadelphia, PA at the Philadelphia Convention Center.
Source: BioTech Now
The Impact of Artificial Intelligence on the Creation of Medicines
October 24th 2024Najat Khan, chief R&D officer, chief commercial officer, Recursion, and Fred Hassan, director, Warburg Pincus, discuss how artificial intelligence can help reduce healthcare costs at the 20th Annual Young & Partners Pharmaceutical Executive Summit held at the Yale Club of New York.
Plan Ahead: Mastering Your AI Budget for 2025 Success
October 9th 2024Generative AI is just one part of the artificial intelligence and machine learning that is being used by life science organizations, emerging as a major area of interest and an area in which costs and ROI are still largely unknown.